Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)

Wasserfallen,  J. B.; Rollier,  P.; Leyvraz,  S.; Perey,  L.

doi:10.1023/A:1008308115848

Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)

Details

Download: REF.pdf (229.80 [Ko])
State: Public
Version: Final published version
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.

Serval ID

serval:BIB_C6FF10774C6D

Type

Article: article from journal or magazin.

Publication sub-type

Letter (letter): Communication to the publisher.

Collection

Publications

Institution

UNIL/CHUV

Title

Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)

Journal

Annals of Oncology

Author(s)

Wasserfallen J. B., Rollier P., Leyvraz S., Perey L.

ISSN

0923-7534 (Print)

Publication state

Published

Issued date

02/1999

Volume

10

Number

2

Pages

243-4

Notes

Comparative Study
Letter --- Old month value: Feb

Keywords

Aged Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carcinoma, Small Cell/*drug therapy Cisplatin/administration & dosage Doxorubicin/administration & dosage Etoposide/administration & dosage Health Care Costs *Hematopoietic Stem Cell Transplantation Humans Ifosfamide/administration & dosage Lung Neoplasms/*drug therapy Middle Aged

URN

urn:nbn:ch:serval-BIB_C6FF10774C6D9

OAI-PMH

oai:serval.unil.ch:BIB_C6FF10774C6D

DOI

10.1023/A:1008308115848

Pubmed

10093698

Web of science

000079290000026

Open Access

Yes